MOG and myeloid sarcoma: Studying the myelin oligodendrocyte glycoproteins has be found that [Asn31(Glc)]hMOG(30–50) glycoprotein is able to differentiate the serum of MS positive patients from the serum of MS negative ones, recognizing the autoantibodies developed by MS patients.